Almathera. Production of Radiopharmaceuticals

The Almathera site is located in Almaty, a vibrant, multicultural city

nestled at the foot of the beautiful Alatau mountains.

As one of the region's most modern cities, Almaty offers excellent infrastructure, a growing healthcare sector, and direct access to key markets. Its strategic position at the crossroads of Europe and Asia provides unparalleled connectivity, making it the ideal hub for cutting-edge healthcare innovations. Our facility will operate as a CDMO and will be GxP-compliant, ensuring the highest standards in quality and manufacturing for the life sciences sector.

The Almathera site is located in Almaty, a vibrant, multicultural city nestled at the foot of the beautiful Alatau mountains.

As one of the region's most modern cities, Almaty offers excellent infrastructure, a growing healthcare sector, and direct access to key markets. Its strategic position at the crossroads of Europe and Asia provides unparalleled connectivity, making it the ideal hub for cutting-edge healthcare innovations. Our facility will operate as a CDMO and will be GxP-compliant, ensuring the highest standards in quality and manufacturing for the life sciences sector.

CURRENT STATUS

Our facility is in the pre-design phase, with detailed design work underway
Construction is planned to begin in the fall of 2025
Testing and operational trials are anticipated Q1 2027

THERANOSTICS SOLUTIONS

Our products:

Ga-68
Cu-64
Lu-177

CDMO SERVICES

We offer full-scale CDMO services, from development to manufacturing, ensuring that your projects meet the highest quality standards

R&D
COLLABORATION

Our open-minded platform welcomes partnerships for research and development, fostering innovation in radiopharmaceuticals and isotope production

TECHNOLOGICAL PARTNERS

SCIENTIFIC PARTNERS

INFORMATION PARTNERS

Significance of the project

Main advantages

1

It will reduce the issue of availability of high-tech and innovative molecular imaging methods and personalized radioligand therapy (theranostics with Lu177)

2

It will enable the development and production of radiopharmaceuticals for theranostics of various diseases, primarily for endocrine and oncological conditions

3

It will become a new point on the global map of logistics and GMP (Good Manufacturing Practice) production of Lu177 radiopharmaceuticals

4

It will establish a unique multidisciplinary cluster of experts, including medical professionals, biologists, chemists, and physicists, with the participation of international partners

5

Additional job opportunities for young and promising specialists in the fields of radiopharmaceuticals, radiochemistry, nuclear medicine, medical physics, radiobiology, IT technologies, etc.

PROCESS Lu 177

IRRADIATION OF YB-176 TARGET IN THE REACTOR

TECHNOLOGY NCA
LU-177

PACKAGING IN A MULTI-DOSE VIAL NCA LU-177 GMP EU SUBSTANCE

RADIOLIGAND BINDING TECHNOLOGY

PACKAGING IN A
MULTI-DOSE VIAL NCA
LU-177 - RADIOLIGAND
(GMP EU)

PROCESS Ga 68 | Cu 64

CYCLOTRON PRODUCTION OF ISOTOPES

USING LIQUID TARGETS OF IBA

RADIOCHEMICAL SYNTHESIS TECHNOLOGY

PSMA-FAPI-DOTA Ga-PSMA-DOTA-Peptides

PACKAGING IN A MULTI-DOSE VIAL OF A RADIOPHARMACEUTICAL

FOR PET DIAGNOSTICS (GMP EU)

Location plan
Location of the projected site on the territory of the SEZ Park of Innovative Technologies

BECOME PART OF OUR TEAM

We are hiring high-level specialists

APPLY NOW

News